In a recent survey conducted by MobiHealthNews, executives in the healthcare industry highlighted the transformative potential of artificial intelligence (AI) in the sector. When asked about how they see AI’s place in healthcare changing in 2025, several key themes emerged, showcasing the vast opportunities AI presents in revolutionizing patient care, diagnostics, provider burnout, drug development, and overall healthcare outcomes.
Dr. Michael Howell, chief clinical officer at Google, emphasized the importance of multimodal AI in healthcare. He mentioned that AI capable of understanding not just text but also pictures, audio, and video will begin to enter healthcare in a serious way in 2025. This advancement will enable AI to assist in completing complex tasks and enhance diagnostic accuracy, ultimately improving patient care.
Roland Rott, president and CEO of imaging at GE HealthCare, discussed the significant impact AI is already having in diagnostic imaging. He highlighted how AI-powered diagnostic imaging can help radiologists detect subtle abnormalities that may be impossible to discern with the human eye. Rott predicted that in 2025, AI will further improve diagnostic accuracy by addressing challenges related to image quality and patient movement during scans.
Matt Cybulsky, practice leader of healthcare AI, data, and product innovation at LBMC, offered a more holistic perspective on AI in healthcare. He emphasized that AI is not a standalone tool but rather a growing technology with both fallibility and promise. Cybulsky stressed the importance of integrating AI into healthcare while retaining human qualities and interactions, acknowledging that AI will continue to evolve and inspire in the coming years.
Lisa Suennen, managing partner at American Heart Association Ventures, expressed skepticism regarding the clinical adoption of AI in healthcare. She highlighted barriers such as fear, misaligned incentives, and discomfort with data that are hindering the integration of AI into clinical practice. Suennen suggested that it may take time for healthcare providers to fully embrace AI due to these challenges.
Despite varying perspectives on the role of AI in healthcare, executives like Aaron Neiderhiser, cofounder and CEO of Tuva Health, and Dan Nardi, CEO of Reimagine Care, remain optimistic about the future of AI in the industry. They anticipate that AI will continue to gain traction in healthcare, with real ROI-generating use cases emerging in 2025 and beyond. Nardi emphasized the role of AI in automating processes and improving patient engagement, while Neiderhiser highlighted the potential for AI to navigate provider burnout and care delays.
Looking ahead to 2025, the healthcare industry is poised for further advancements in AI, particularly in drug development and patient care. Brooke Boyarsky Pratt, CEO and cofounder of knownwell, and Liz Beatty, cofounder and chief strategy officer at Inato, both foresee AI playing a crucial role in optimizing treatment strategies, enhancing patient experiences, and bolstering value-based care frameworks.
Overall, the consensus among healthcare executives is that AI has the potential to revolutionize the industry by improving diagnostics, streamlining processes, enhancing patient outcomes, and ultimately transforming the way healthcare is delivered. As we look towards the future, it is clear that AI will continue to be a driving force in shaping the healthcare landscape in 2025 and beyond. The Potential of AI in Drug Development and Healthcare Transformation
The use of artificial intelligence (AI) in drug discovery has been widely discussed, but its potential in drug development is equally significant. Pharmaceutical companies can utilize AI to streamline the drug development process, making it more efficient and bringing new drugs to market faster. This technology can be used both internally within companies and in collaborations with research sites.
Internally, AI can help identify new trial sites with relevant expertise and reduce the number of trial participants needed. By analyzing patient records, AI can also help research sites efficiently prescreen patients, saving time and resources that would have been spent sifting through records manually.
Mimi Winsberg, chief medical officer and cofounder of Brightside Health, believes that AI will revolutionize healthcare by 2025. Clinicians will welcome AI tools as time-saving assistants, allowing them to focus more on patients and less on administrative tasks. These tools will improve diagnostic accuracy, predict treatment response, and provide care insights directly to patients, making mental health care more proactive and personalized.
Dave Wessinger, cofounder and CEO of PointClickCare, sees the intersection of AI and value-based care as a powerful force in healthcare. While skepticism still exists around AI, industry leaders are working to increase awareness of the real value of automation. By integrating AI tools into regular workflows and aligning them with clinical needs, the industry can overcome barriers such as data security concerns and ensure that automation is seen as an asset rather than a threat.
In conclusion, AI has the potential to transform drug development and healthcare in the coming years. By leveraging this technology effectively, pharmaceutical companies and healthcare practitioners can improve efficiency, accuracy, and patient care, ultimately leading to better outcomes for all.
